Optimizing Ophthalmology eviCore Integration for Prior Authorization

Klivira streamlines **ophthalmology eviCore integration**, automating prior authorization workflows for high-volume procedures and specialty medications critical to eye care.

For revenue cycle directors and prior authorization teams in ophthalmology, navigating eviCore Healthcare's specific benefit management requirements can introduce significant administrative burden. From chronic anti-VEGF injection cycles to complex premium IOL authorizations, manual processes risk delays and denials. Klivira provides a robust solution to integrate and automate these critical workflows.

The Intersection of Ophthalmology and eviCore Authorization

Ophthalmology practices frequently encounter eviCore for benefit management, particularly concerning high-cost specialty drugs and advanced surgical procedures. While eviCore is widely known for radiology, cardiology, oncology, and MSK benefit management, its scope can extend to ophthalmic services, requiring precise adherence to their specific authorization policies. Klivira's platform is engineered to manage these diverse payer requirements effectively.

Key Ophthalmology PA Triggers Managed Through eviCore Integration

Anti-VEGF intravitreal injections (e.g., Aflibercept, Ranibizumab, Faricimab) for conditions like wet AMD, DME, RVO.
Cataract surgery involving premium intraocular lenses (IOLs) or specific specialty lens technologies.
Glaucoma surgical procedures, including micro-invasive glaucoma surgery (MIGS), trabeculectomy, and tube shunts.
Corneal procedures such as DSAEK, DMEK endothelial keratoplasty, and corneal cross-linking for keratoconus.
Oculoplastic procedures, particularly functional blepharoplasty for visual-field-affecting ptosis (medical necessity required).

Streamlining eviCore Submissions for Ophthalmic Care

Klivira's platform integrates directly with your EMR, pulling necessary clinical data for eviCore submissions. This includes automating the collection of diagnosis confirmations (e.g., OCT findings for fluid, FA where applicable), visual acuity documentation, and prior treatment responses crucial for chronic anti-VEGF cycles. By leveraging structured data and intelligent workflows, we reduce the manual lift associated with preparing and submitting comprehensive authorization requests.

Critical Documentation for eviCore Ophthalmology PAs

Ophthalmology prior authorizations, often guided by AAO Preferred Practice Patterns, demand specific documentation. For anti-VEGF injections, this includes OCT findings, visual acuity, and step therapy compliance. Premium IOLs require patient acknowledgment of out-of-pocket costs, while functional blepharoplasty mandates visual field tests and photographs. Klivira's system guides users to capture and organize these essential data points, reducing common denial reasons like 'visual field documentation gaps' or 'prior-treatment response gaps'.

Klivira's Role in Optimizing Ophthalmology eviCore Workflows

Klivira addresses the unique workflow constraints of ophthalmology, such as managing chronic anti-VEGF injection cycles and the high volume of clinic-injection encounters. Our platform incorporates AAO-guideline-aware anti-VEGF re-authorization workflows, biosimilar substitution routing per payer policy, and logic for cosmetic-vs-medical determination in oculoplastics. This automation minimizes the administrative burden, allowing clinical staff to focus on patient care rather than repetitive PA tasks.

EMR and Payer Touchpoints for Seamless Integration

Our solution connects to your existing EMR via secure, standardized interfaces, extracting relevant clinical notes, diagnostic images, and order types. For eviCore, this means automated submission via appropriate digital channels, reducing reliance on manual portal entries or fax. This integration ensures that the right clinical context, from OCT-based diagnostic dependence to patient counseling notes for premium lenses, is accurately transmitted to support authorization approvals.

Frequently asked questions

How does Klivira handle the recurring prior authorizations for anti-VEGF injections with eviCore?

Klivira automates the re-authorization process for chronic anti-VEGF injections. Our system tracks treatment cycles, prompts for updated clinical documentation like OCT findings and visual acuity, and applies payer-specific rules for biosimilar substitution, streamlining subsequent eviCore submissions.

Can Klivira help differentiate between cosmetic and medically necessary oculoplastic procedures for eviCore?

Yes, Klivira incorporates logic to guide the documentation process for oculoplastic procedures, helping to clearly establish medical necessity. This includes prompting for required visual field tests and photographic evidence to support claims for procedures like functional blepharoplasty, aligning with eviCore's policy requirements.

What EMR data does Klivira pull to support ophthalmology eviCore prior authorizations?

Klivira extracts critical data points from your EMR, including patient demographics, diagnoses (e.g., wet AMD, DME, keratoconus), procedure codes, medication lists, and clinical notes detailing visual acuity, IOP, OCT findings, and visual field results. This comprehensive data set supports robust eviCore submissions.

How does Klivira address eviCore's requirements for premium IOLs in cataract surgery?

For premium IOLs, Klivira helps ensure all necessary documentation is compiled, including the patient's acknowledgment of out-of-pocket costs and any medical necessity justifications for specific lens technologies. This structured approach minimizes denials related to coverage or documentation gaps for specialty lenses.

Does Klivira integrate with eviCore's specific submission portals or channels?

Klivira is designed to connect with various payer channels and portals, including those utilized by eviCore Healthcare. Our platform automates the submission process, ensuring that authorization requests are sent through the most efficient and compliant digital pathways available, reducing manual portal interaction.